期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

94例成人急性普通B淋巴细胞白血病CD20表达与预后相关分析 被引量：3

暂未订购
导出
摘要 急性淋巴细胞白血病（acutelymphoblasticleukemia，ALL）是淋巴细胞恶性增殖性疾病，起源于单克隆B淋巴细胞或T淋巴细胞的前体细胞，其中急性B淋巴细胞白血病根据细胞表面分化抗原的表达，依次分为早前B型、普通B型、前B型、成熟B细胞型，患者在生物学行为和预后方面有很大的异质性，对治疗反应有很大差别。
作者 王亚婷 杨雷 国巍 白欧
机构地区 吉林大学第一医院肿瘤中心
出处 《中国实验诊断学》 2013年第1期122-124,共3页 Chinese Journal of Laboratory Diagnosis
关键词 急性淋巴细胞白血病 预后相关分析 CD20 细胞表面分化抗原 恶性增殖性疾病 B淋巴细胞 成人 T淋巴细胞
分类号 R733.7 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1ThomasDA,O'Brien S,Jorgensen JL,et al. Prognostic significanceof CD20 expression in adults with de novo precursor B-lineage a-cute lymphoblastic leukemia[J] . Blood,2009 ,113(25) : 6330.
  • 2CraggMS, Walshe CA, Ivanov AO,et al. The biology of CD20 andits potential as a target for mAb therapy [J] . Curr Dir Autoim-mun,2005,8 : 140.
  • 3秘营昌.成人急性淋巴细胞白血病的规范化诊断及治疗[J].临床血液学杂志,2012,25(3):265-267. 被引量：11
  • 4赖增祖,熊冬生,范冬梅,许元富,刘汉芝,彭晖,朱祯平,杨纯正.抗CD20嵌合Fab′片段对B淋巴瘤细胞的生长抑制作用[J].科学通报,2001,46(1):61-65. 被引量：4
  • 5uximab resistance in lymphoma cell lines is associated with bothglobal CD20 gene and protein down-regulation regulated al theprelranscriptional and post transcriptional levels [ J ] . Clin C'a nccrRes,2008,14(5):1561.
  • 6Jazirehi AR, Bonavida B. Development of rituximab-resist am H-NHL clones: an in vitro model for studying tumor resistance tomonoclonal antibody-mediated immunotherapy[J] . Methods MolBiol,2011,731 :407.
  • 7GokbugetN,Hoelzer D. Treatment with monoclonal antibodiesin acute lymphoblastic leukemia: current knowledge and futureprospects[J] . Ann Hematol, 2004,83 : 201.
  • 8JehaS, Behm F,Pei D, et al. Prognostic significance of CD20 ex-pression in childhood B-cell precursor acute lymphoblastic leuke -mia[J] . Blood,2006,108(10):3302.
  • 9ChangH,Jiang A,Brandwein J. Prognostic relevance of ('D20 inadult B-cell precursor acute lymphoblastic leukemia[J] . Haematologica,2010,95(6);1040.
  • 10SmithL J ,Curtis J E,Messner H A, et al. Lineage infidelity in a-cute leukemia[JJ. Blood,1983,61:1 ] 38.

二级参考文献24

  • 1ROWE J, BUCK G, BURNETT A, et al, Induction therapy for adults with acute lymphoblastic leukemia.. results of more than 1 500 patients from the international ALL trial:MRC UKALLXII/ECOG E2993[J]. Blood, 2005,106 : 3760-3767.
  • 2HUGUET F, LEGUAY T, RAFFOUX E, et al. Pediatric-inspired therapy in adults with philadelphia chromosome-negative acute lymphoblastic leukemia: the graall-2003 study[J]. J Clin Oncol, 2008,27:1-8.
  • 3STOCK W, LA M, BEN SANFORD B, et al. What determines the outcomes for adolescents and young a- dults with acute lymphoblastic leukemia treated on cooperative group protocols? Acomparison of Chil- dren's Cancer Group and Cancer and Leukemia Group B studies[J]. Blood, 2008,112:1646-1654.
  • 4NACHMAN J,LA M, HUNGER S,et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduetion treatment:A report from the Children's oncology group[J]. J Clin Oncol,2009, 27:5189-5194.
  • 5KANTAP, JIAN H,THOMAS D,O'BRIEN S,et al. Long-term follow-up results of hyperfractionated cy- clophosphamide vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in acute lymphoblastic leukemia [J]. Cancer, 2004, 101:2788-2801.
  • 6WASSMANN B, PFEIFER H, GOEKBUGET N, et al. Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) [J]. Blood, 2006,108:1469-1477.
  • 7THOMAS D A, KANTARJIAN H M, CORTES J E, et al. Outcome after Irontline therapy with the hyper-CVAD and imatinib mesylate regimen for adults with de nov0 or minimally treated Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL)[J]. Proc Am Clin Soc Oncol, 2008,26:7019a.
  • 8YANADA M, SUGIURA I, TAKEUCHI J, et al. Japan Adult Leukemia Study Group. Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia un- dergoing imatinib-combined chemotherapy[J]. Br J Haematol, 2008,143 : 503-510.
  • 9BASSAN R, ROSSI G, POGLIANI E M, et al. Chemo therapy-phased imatinib pulses improve long-term outcome of adlut patients with Philadelphia chromosomepositive acute lymphohlastic leukemia: Northern Italy Leukemia Group Protocol 09/00[J]. J Clin Oncol, 2010, 28:3644-3652.
  • 10OTTMANN OG, WASSMANN B, PFEIFER H, et al. Imatinih compared with chemotherapy as frontline treatment of elderly patients with Philadelphia chromo somepositive acute lymphoblastic leukemia (Ph+ ALL) [J]. Cancer, 2007,109 : 2068-2076.

共引文献13

同被引文献29

  • 1Weiner RS, Pelayo R, Kincade PW. Evolving views on the gene-alogy of B cells . Nat Rev Immunol,2008 , 8(2) :95-106.
  • 2Lutz J, Heideman MR, Roth E, et al. Pro-B cells sense produc-tive immunoglobulin heavy chain rearrangement irrespective of pol-ypeptide production . Pnas, 2011,108(26) : 10644-10649.
  • 3Ito R, Katano I,Tanaka MI, et al. Efficient xenoengraftment insevere immunodeficient NOD/Shi-scid IL2rynulI mice is attributedto a lack of CDllc + B220 + CD122 + cells . The Journal of Im-munology, 2012,189(9) : 43134320.
  • 4Wang K, Wei G, Liu D. CD19 : a biomarker for B cell develop-ment ,lymphoma diagnosis and therapy . Experimental Hematology& Oncology, 2012,1(1) :36.
  • 5Park JH, Resnick ES, Cunningham-Rundles C. Perspectives oncommon variable immune deficiency . New York Academy of Sci-ences, 2011, 1246; 4149.
  • 6Rupniewska ZM, Roliftski J, Bojarska-Junak A. Universal CD43molecule . Postepy Hig Med Dosw, 2000, 54(5) :619-38.
  • 7Geier JK, Schlissel MS. Pre-BCR signals and the control of Iggene rearrangements . Seminars in Immunology, 2006, 18(1):31-39.
  • 8Bednarski JJ, Nickless A, Bhattacharya D, et al. RAG-inducedDNA double-strand breaks signal through Pim2 to promote pre-Bcell survival and limit proliferation . The Rockefeller UniversityPress, 2011, 209(1) :11-17.
  • 9Ichii M, Oritani K, Yokota T,et al. The "density of CD10 corre-sponds to commitment afid progression in the human B lymphoidlineage . Plos one, 2010,5(9) : 12954.
  • 10Mikami Y,Hata S, Kiyokawa T, et al. Expression of CD10 inmalignant miillerian mixed mumors and adenosarcomas : an immu-nohistochemical study . Mod Pathol,2002,15(9) :923-930.

引证文献3

二级引证文献3

中国实验诊断学
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部